ACNB Corporation Reports Strong Q1 Profit Turnaround, Improved Asset Quality, and Robust Capital
ACNB sits 33% above its 52-week low of $40.15 on light trading volume (0.2× avg).
Summary
ACNB Corporation posted a strong Q1 2026, reversing last year's loss with $13.7 million in net income, driven by higher net interest income and improved asset quality.
Key Events · Earnings and Guidance · ACNB
-
Strong Earnings Turnaround
Net income surged to $13.7 million ($1.32 diluted EPS) in Q1 2026, a significant recovery from a net loss of $0.272 million ($0.03 diluted loss per share) in Q1 2025.
-
Net Interest Income Growth
Net interest income increased by 19.9% to $32.5 million, with the net interest margin expanding by 39 basis points to 4.46%.
-
Improved Asset Quality
The company reported a reversal of $76 thousand in provision for credit losses, compared to a $6.0 million provision in the prior year, and a 10.6% decrease in non-performing loans to $9.585 million.
-
Robust Capital Position
All regulatory capital ratios significantly exceeded "well-capitalized" thresholds, with Tier 1 Leverage at 11.74% and Total Capital at 16.73% as of March 31, 2026.
Analysis · ACNB · Finance
ACNB Corporation delivered a significant financial turnaround in Q1 2026, reporting a net income of $13.7 million and diluted EPS of $1.32, a substantial improvement from a net loss in the prior year. This performance was driven by a 19.9% increase in net interest income and a 39 basis point expansion in net interest margin, benefiting from balance sheet restructuring and new loans at higher rates. The company also demonstrated improved asset quality with a reversal of credit loss provisions and a decrease in non-performing loans. Strong capital ratios further underscore the company's solid financial health.
At the time of this filing, ACNB was trading at $53.37 on NASDAQ in the Finance sector, with a market capitalization of approximately $552.6M. The 52-week trading range was $40.15 to $53.91. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.